Portfolio

Peptomyc Expands its Patent Portfolio with a Patent Grant in Hong Kong for its Methods and Composition for the Treatment of Cancer

August 19, 2024

Peptomyc S.L., a company developing foundational mini-protein therapeutics for the treatment of cancer, announces today that the Company has been issued a patent by the Hong Kong Patent Office protecting its Methods and Composition of Matter.

 

Read more